- Home
- NKSH vs SCPH Comparison
NKSH vs SCPH Comparison
Compare NKSH & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKSH
- SCPH
- Stock Information
- Founded
- NKSH 1891
- SCPH 2013
- Country
- NKSH United States
- SCPH United States
- Employees
- NKSH N/A
- SCPH N/A
- Industry
- NKSH Major Banks
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- NKSH Finance
- SCPH Health Care
- Exchange
- NKSH Nasdaq
- SCPH Nasdaq
- Market Cap
- NKSH 172.6M
- SCPH 299.0M
- IPO Year
- NKSH N/A
- SCPH 2017
- Fundamental
- Price
- NKSH $29.81
- SCPH $5.61
- Analyst Decision
- NKSH Strong Buy
- SCPH Buy
- Analyst Count
- NKSH 1
- SCPH 3
- Target Price
- NKSH $38.00
- SCPH $12.00
- AVG Volume (30 Days)
- NKSH 8.4K
- SCPH 2.3M
- Earning Date
- NKSH 10-23-2025
- SCPH 11-12-2025
- Dividend Yield
- NKSH 4.91%
- SCPH N/A
- EPS Growth
- NKSH 15.57
- SCPH N/A
- EPS
- NKSH 1.77
- SCPH N/A
- Revenue
- NKSH $49,801,000.00
- SCPH $49,969,000.00
- Revenue This Year
- NKSH $2.95
- SCPH $108.95
- Revenue Next Year
- NKSH $9.97
- SCPH $78.30
- P/E Ratio
- NKSH $17.34
- SCPH N/A
- Revenue Growth
- NKSH 16.22
- SCPH 107.79
- 52 Week Low
- NKSH $23.75
- SCPH $1.94
- 52 Week High
- NKSH $32.89
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- NKSH 48.05
- SCPH 63.30
- Support Level
- NKSH $30.52
- SCPH $4.33
- Resistance Level
- NKSH $31.47
- SCPH $5.62
- Average True Range (ATR)
- NKSH 0.69
- SCPH 0.04
- MACD
- NKSH -0.18
- SCPH 0.00
- Stochastic Oscillator
- NKSH 18.78
- SCPH 78.57
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.